Accessibility Menu
 
Igene Biotechnology logo

Igene Biotechnology

(OTC) IGNE

Current Price$0.00
Market Cap$1,600
Since IPO (1990)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Igene Biotechnology Financials at a Glance

Market Cap

$1,600

Revenue (TTM)

$4.80K

Net Income (TTM)

$2.37M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

4.60 (High)

Price

$0.00

Volume

2,137,668

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

IGNE News

No articles available.

IGNE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Igene Biotechnology

Industry

Chemicals

Sector

Materials

Headquarters

Columbia, MD 21045, US

IGNE Financials

Key Financial Metrics (TTM)

Gross Margin

26%

Operating Margin

-27%

Net Income Margin

-4%

Return on Equity

0%

Return on Capital

-33%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.60K

Shares Outstanding

1.57B

Volume

2.14M

Short Interest

0.00%

Avg. Volume

34.48K

Financials (TTM)

Gross Profit

$1.02M

Operating Income

$1.07M

EBITDA

$851.29K

Operating Cash Flow

$97.05K

Capital Expenditure

$171.78K

Free Cash Flow

$268.83K

Cash & ST Invst.

$1.30M

Total Debt

$6.80M

Igene Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2010YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.60K

N/A

Market Cap/Employee

$88.89

N/A

Employees

18

N/A

Net Income

$627.24K

-646.3%

EBITDA

$57.76K

-109.4%

Quarterly Fundamentals

Name
Q3 2010YOY CHG

Net Cash

$7.07M

-49.0%

Accounts Receivable

$2.17M

+16.7%

Inventory

$0.00

N/A

Long Term Debt

$5.72M

+0.7%

Short Term Debt

$1.61M

-4.1%

Return on Assets

-2.96%

N/A

Return on Invested Capital

-33.43%

N/A

Free Cash Flow

$710.59K

-3.0%

Operating Cash Flow

$710.59K

-3.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SLSDFSelect Sands Corp.
$0.00+0.00%
GRENGreensmart Corp
$0.00+0.00%
CBLRFCampbell Resources Inc.
$0.00+0.00%
PNGMPengram Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About IGNE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.